Camillo Golgi and the pathology of Huntington's disease: An unresolved controversy

Sergio Rebora1, Mauro Colombo2, Marjolein Breur3

  • 1Azienda di Servizi alla Persona Golgi Redaelli, Milano, Italia.

Insights

Camillo Golgi

Area of Science:

  • Neuropathology
  • Neuroscience
  • Medical History

Background:

  • In 1874, Camillo Golgi documented neuropathological findings in a patient with chronic chorea and dementia.
  • The study identified impairments in the frontal-parietal and temporal cortices, striatum, and cerebellum.
  • This work predates commonly accepted first descriptions of cortico-striatal involvement in choreic movement disorders.

Purpose of the Study:

  • To evaluate the neuropathological findings of Camillo Golgi's 1874 case study in the context of Huntington's disease.
  • To address the ongoing debate regarding the diagnosis of Golgi's patient as potentially having Huntington's disease.
  • To investigate the patient's family history through genealogical studies to support or refute the Huntington's disease diagnosis.

Main Methods:

  • Review of Golgi's 1874 neuropathological study.
  • Clinical-anatomical correlation analysis.
  • Genealogical research to trace family history and identify potential choreic patients or Huntington's disease associations.

Main Results:

  • Golgi's study detailed neuropathological changes in brain regions consistent with chorea.
  • Genealogical studies did not reveal a family history of chorea or association with known Huntington's disease families in the region.
  • The absence of definitive family history complicates the diagnostic debate but does not negate the neuropathological findings.

Conclusions:

  • Camillo Golgi's 1874 study represents a significant early neuropathological description of chronic chorea.
  • While the diagnosis of Huntington's disease remains debated due to lack of family history and genetic/histological data, Golgi's work is a landmark in understanding chorea's neuropathology.
  • The study underscores the importance of historical neuropathological records in advancing the understanding of neurodegenerative diseases.

Related Concept Videos

Golgi Apparatus01:09

Golgi Apparatus

Properly folded and assembled proteins are selectively packaged into vesicles that exit the ER. Motor proteins transport these vesicles to the Golgi apparatus for adding modifications that make these proteins functional at their destination.
The Golgi apparatus is a eukaryotic organelle that has a distinctive ribbon-like appearance. It is a primary sorting and dispatch station for cargo arriving from the ER. Newly arriving vesicles enter the cis face of the Golgi, closest to the ER, and are...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Transport Across the Golgi01:26

Transport Across the Golgi

While it is unclear how molecules move between adjacent Golgi cisternae, it is apparent that the molecules move from cis- cisterna, the entry face, to the trans- cisterna, the exit face. Experiments initially suggested vesicles that bud from one cisterna and fuse with the next cisterna to transport proteins between the cisternae. This vesicular transport model describes the Golgi apparatus as a relatively static structure with a unique enzyme composition in each cisterna. Molecules are...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...